Attached files
| file | filename |
|---|---|
| EX-32.1 - CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION - BRAIN SCIENTIFIC INC. | f10k2020ex32-1_brainsci.htm |
| EX-31.2 - CERTIFICATION PURSUANT TO SECURITIES EXCHANGE ACT RULE 13(A)-14(A), AS ADOPTED P - BRAIN SCIENTIFIC INC. | f10k2020ex31-2_brainsci.htm |
| EX-31.1 - CERTIFICATION PURSUANT TO SECURITIES EXCHANGE ACT RULE 13(A)-14(A), AS ADOPTED P - BRAIN SCIENTIFIC INC. | f10k2020ex31-1_brainsci.htm |
| 10-K - ANNUAL REPORT - BRAIN SCIENTIFIC INC. | f10k2020_brainscientificinc.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Brain Scientific Inc. (the “Company”) on Form 10-K for the fiscal year ended December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Mark Corrao, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the company.
| /s/ Mark Corrao | ||
| Mark Corrao | ||
| Chief Financial Officer | ||
| April 15, 2021 |